Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05747092
Other study ID # B7072021000061
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 14, 2022
Est. completion date June 2023

Study information

Verified date February 2023
Source University of Liege
Contact leila Salhi, PhD
Phone 0484888091
Email l.salhi@chuliege.be
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Is the pain killer consumption after gingival treatment related to the level of patient anxiety or to the type of therapy?


Description:

Anxiety and depression (HAD) scale used could be reveal the level of the patient anxiety and/or depression before intervention. Additionnaly the use of these specific questionnaires (7 items for anxiety, 7 items for depression) could reveal if the pain killer consumption after gingical treatment is dependant to the level of HAD or to the therapy . This tool (HAD) could allows to recognize, before any (oral)surgery, profil with high risk and propose solution to decrease anxiety and/or depression before treatment.


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date June 2023
Est. primary completion date February 14, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 99 Years
Eligibility Inclusion Criteria: - ASA type I and II subjects - Localized Gingival Recessions - Recessions Cairo RT I-II - FMPS < 10% - FMBS< 10% - <10 cigs/ day - No contra-indication against oral surgical interventions - Patient is able to give inform consent Exclusion Criteria: - Infection (local or systemic). Each infection will be evaluated prior to study procedure for suitability. Patients with gingivitis or local infection (fracture, apical reaction) will undergo a dental treatment prior to his entrance to the study. In case of systemic infection, the evaluation will be based on medical anamneses, and if necessary will be referred to relevant medical tests. - ASA type > II - Current pregnancy or breastfeeding women - Alcoholism or chronically drug abuse - Smokers, ? 10 cigarettes per day - Immunocompromised patients - Uncontrolled diabetes - Untreated periodontitis - History of previous periodontal surgery (mucogingival or other) on the teeth to be included - Presence of severe tooth malposition, rotation or significant version of the tooth to be treated

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
gingival graft
investigators: Donor site: tissue graft harvesting from the palate behind the palatal rugae . placement of a palatine hemostatic plaque on the palate in order to reduce the risk of bleeding and to diminish the postoperative pain. Received site: Control: the horizontal incision adjacent to the recession(s) and vertical incisions and split thickness flap. Placement of the graft on the recipient bed and suture. Test :connective tissue graft using the " envelope/pouch " technique with two partial thickness incisions (deep and superficial). Placement of the graft inside the envelope

Locations

Country Name City State
Belgium leila Salhi Liège Liege

Sponsors (1)

Lead Sponsor Collaborator
University of Liege

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary pin killer consumption the number of pain killer used after treatment two weeks
See also
  Status Clinical Trial Phase
Withdrawn NCT04989972 - Assessing the Efficacy of Micro-dosed Psilocybin on Reducing Anxiety & Depression Levels in Adults Phase 2
Completed NCT04925765 - Virtual Reality Biofeedback for Postpartum Anxiety and Depression N/A
Not yet recruiting NCT06188923 - A New Intervention to Improve Function in Veterans With Anxiety and Depression Phase 2
Recruiting NCT06116812 - The Effect of Laughter and Mindfulness Therapy Applications on Women With Breast Cancer Receiving Chemotherapy: Randomized Controlled Study N/A
Completed NCT01197313 - Depression and Quality of Life in Chronic Heart Failure Patients and the Caregivers N/A